Ellis Andrea bought BBIO
August 5, 2025 · Form 4 insider transaction
Ellis Andrea bought 17,167 shares of BridgeBio Pharma, Inc. at $16.75 per share, a transaction worth $287.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,167
Price
$16.75
Total value
$287.5K
InsiderEllis Andrea
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 5, 2025
Filing dateAugust 7, 2025
Shares owned after35,756
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.